Mogg dumps shares in abor­tion pill com­pany

Firm No 2 linked to pro-life MP

Sunday Mirror - - FRONT PAGE -

than six mil­lion a year are car­ried out on the sub­con­ti­nent. The MP for North East Som­er­set said he did not make in­vest­ment de­ci­sions and de­fended the hold­ing in the In­dian firm as “very small in pro­por­tion to to­tal as­sets”.

The £467,800 worth of shares was just a tenth of the £4.8mil­lion that Som­er­set Cap­i­tal still holds in Kalbe Farma.

But the MP added of the FDC hold­ing: “I am glad to say it’s a stock that we no longer hold. I would not try to de­fend in­vest­ing in com­pa­nies that did things I be­lieve are morally wrong.”

FDC, which ex­ports to 50 coun­tries, pro­duces two drugs which, when used to­gether, pro­duce a ter­mi­na­tion of the same sort rou­tinely given by the NHS.

The Mum­bai-based firm makes miso­pros­tol un­der the brand name Miso­last and mifepri­s­tone branded as Undo. In­dian drugs web­site In­phar­ma­tion lists both drugs as be­ing for the ter­mi­na­tion of preg­nancy.

Miso­pros­tol can also be pre­scribed to pre­vent stom­ach ul­cers, but will in­duce labour in preg­nant women. In preg­nan­cies of up to 12 weeks, it re­sults in a ter­mi­na­tion in nine out of ten cases.

TABLETS OF STONE Rees-Mogg is un­yield­ing on abor­tion

Newspapers in English

Newspapers from UK

© PressReader. All rights reserved.